Insider · CIK 0001667937

Ali Faraz

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001667937

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+122K sh	—	—	539,782
2026-09-10	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+733K sh	—	—	732,500
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,837 sh	$0.71	−$4,142.519	434,177
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,969 sh	$0.71	−$2,817.196	430,208
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,020 sh	$0.71	−$3,562.694	425,188
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,406 sh	$0.71	−$5,256.038	417,782
2026-05-18	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,390 sh	$0.79	−$2,689.626	440,014
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,851 sh	$0.64	−$3,762.193	452,415
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,979 sh	$0.64	−$2,558.895	448,436
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,032 sh	$0.64	−$3,235.576	443,404
2026-02-03	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+159K sh	—	—	458,266
2026-02-03	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+952K sh	—	—	952,250
2025-11-17	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,126 sh	$1.33	−$4,157.58	299,666
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,720 sh	$1.25	−$7,167.16	311,605
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,893 sh	$1.25	−$4,877.929	307,712
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,920 sh	$1.25	−$6,164.76	302,792
2025-05-16	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,189 sh	$0.44	−$1,411.77	317,325
2025-03-10	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,794 sh	$0.54	−$3,119.49	324,461
2025-03-10	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,947 sh	$0.54	−$2,125.065	320,514
2025-02-06	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+108K sh	—	—	295,831
2025-02-06	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+34.4K sh	—	—	330,255
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−353K sh	—	—	0
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+353K sh	—	—	353,271
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−161K sh	—	—	0
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+161K sh	—	—	161,214
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−401K sh	—	—	0
2025-02-06	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+401K sh	—	—	401,390
2024-08-16	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,802 sh	$2.89	−$16.8K	192,277
2024-08-16	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,946 sh	$2.89	−$11.4K	188,331
2024-02-23	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+85K sh	—	—	198,079
2024-02-23	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+505K sh	—	—	505,000
2024-02-16	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,358 sh	$5.86	−$37.3K	113,079
2023-08-16	TNYATenaya Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,563 sh	$3.81	−$21.2K	119,437
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,000
2023-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+675K sh	—	—	675,000
2022-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+401K sh	—	—	401,390
2017-01-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+25.2K sh	—	—	25,200
2016-03-02	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Sep 114
Ali Faraz0001193125-26-389563
SEC(opens sec.gov)
Aug 174
Ali Faraz0001193125-26-354518
SEC(opens sec.gov)
May 194
Ali Faraz0001193125-26-231324
SEC(opens sec.gov)
Feb 174
Ali Faraz0001193125-26-055442
SEC(opens sec.gov)
Feb 54
Ali Faraz0001193125-26-039760
SEC(opens sec.gov)
Nov 174
Ali Faraz0001193125-25-284996
SEC(opens sec.gov)
Aug 184
Ali Faraz0001667937-25-000006
SEC(opens sec.gov)
May 164
Ali Faraz0000950170-25-073823
SEC(opens sec.gov)
Mar 104
Ali Faraz0000950170-25-036770
SEC(opens sec.gov)
Feb 74
Ali Faraz0000950170-25-016582
SEC(opens sec.gov)

Companies

Address

C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLOOR

SOUTH SAN FRANCISCO, CA, 94080